Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep624 | Endocrine-related Cancer | ECE2023

Factors associated with dysglycemia and its post-surgical resolution in patients with Pheochromocytomas and Paragangliomas

Zhao Lin , Liu Yecheng , Zhou Xianliang

Background: Pheochromocytomas and paragangliomas (PPGLs) are a group of rare neuroendocrine tumors. Dysglycemia has been observed in patients with PPGLs in some small case series. However, few large studies, and none in China, have described the outcomes of dysglycemia after resection, and the factors associated with the development and resolution of dysglycemia in patients with PPGLs.Methods: We retrospectively analyzed the clinical data of consecutive ...

ea0090ep285 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Effects of Diabetes on Clinical Outcomes of Psoriatic Patients With Coronary Artery Disease

Zhao Lin , Sun Lin , Zeng Yan , Zhou Xianliang

Background: Psoriasis is associated with a heightened prevalence of cardiovascular risk factors, including diabetes. However, it is not clear whether diabetes will cause differences on clinical outcomes of psoriatic patients who have already suffered from coronary artery disease.Methods: We conducted a retrospective cohort study of consecutive psoriatic patients with coronary artery disease between January 2017 and May 2022 in our hospital. The clinical ...

ea0090ep404 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Effects of Metabolic Syndrome on Cardiovascular Outcomes of Psoriatic Patients With Coronary Artery Disease

Zhao Lin , Sun Lin , Zeng Yan , Zhou Xianliang

Background: Psoriasis is associated with a heightened prevalence of cardiovascular risk factors, including metabolic syndrome (MetS). As so far, it is not clear whether MetS will cause differences on clinical outcomes of psoriatic patients who have already suffered from coronary artery disease.Methods: We conducted a retrospective cohort study to determine the effects of MetS in psoriatic patients with coronary artery disease. Comparisons were made betwe...

ea0037gp.23.03 | Thyroid – diagnosis | ECE2015

Incremental value of serial preablative thyroglobulin measurements in identifying distant metastatic differentiated thyroid cancer

Zhao Teng , Liang Jun , Lin Yansong , Li Xiaoyi , Li Tianjun , Yang Ke

Introduction: Thyroglobulin plays a vital role in the follow-up of patients with differentiated thyroid carcinoma (DTC) after thyroidectomy combined with radioiodine (RAI) ablation. As to preablative stimulated thyroglobulin (ps-Tg), though several studies have manifested its potential in identifying distant metastatic DTC (DM-DTC), it remains unclear whether a single ps-Tg is sufficient for predicting DM-DTC. This retrospective study was aimed to evaluate the utility of seria...

ea0099ep1279 | Late Breaking | ECE2024

A rapid and concise dual-mode aptasensor for ultrasensitive detection of 17β-estradiol

Zhao Fengfeng

Objective: Pollution of endocrine disrupting chemicals has become a global issue. As one of the hormonally active compounds, 17β-estradiol produces the strongest estrogenic effect when it enters the organism exogenously including food intakes, bringing potential harmfulness such as malfunction of the endocrine system. Therefore, in order to assure food safety and avoid potential risks of 17β-estradiol to humans, it is of great significance to develop rapid, sensitive...

ea0028s1.2 | Genetic regulation of pituitary tumorigenesis | SFEBES2012

Modelling pituitary tumours in zebrafish

Liu Ning-Ai , Jiang Hong , Ben-Shlomo Anat , Wawrowsky Kolja , Fan Xue-Mo , Lin Shuo , Melmed Shlomo

The pituitary is highly sensitive to cell cycle disruptions. Although CDK gene mutations have not readily been identified in human pituitary tumors, overexpression of cyclins and dysregulation of CDK inhibitors are encountered in pituitary adenomas, indicating the importance of CDK activation for potential therapeutic targeting. However, it is difficult to predict which CDK inhibitor(s) may be effective against particular tumor types in vivo. Therefore, animal models fa...

ea0077oc2.5 | Endocrine Cancer and Late Effects | SFEBES2021

A novel MiR-346-Directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer

Fletcher Claire , Orafidiya Folake , Deng Lin , Yuan Wei , Lorentzen Marc , Cyran Oliwia , Varela-Carver Anabel , Constantin Theodora , Dobbs Felix , Figueiredo Ines , Gurel Bora , Parkes Eileen , Bogdan Denisa , Pereira Ronnie , Zhao Shuang (George) , Neeb Antje , Issa Fadi , Hester Joanna , Kudo Hiromi , Liu Yang , Philippou Yiannis , Bristow Robert , Knudsen Karen , Bryant Richard , Feng Felix , Reed Simon , Mills Ian , de Bono Johann , Bevan Charlotte

MiR-346 is an Androgen Receptor (AR)-activating miR that associates with DNA damage response (DDR)-linked transcripts in prostate cancer (PC). MiR-346 induces rapid and extensive DNA damage in PC cells through chromatin association, activation of transcription, R-loop formation and DNA replication stress, leading to checkpoint activation and cell cycle arrest. MiR-346 interacts with lncRNA, NORAD, in PC cells, which functions to maintain mitosis, DDR, and chromosomal integrity...

ea0070oc4.4 | Pituitary and Neuroendocrinology | ECE2020

Thyrotropin/Thyrotropin receptor signaling deficiency impairs spatial learning and memory

Luan Sisi , Hou Xu , He Zhao , Zhao Jiajun

Purpose: Subclinical hyperthyroidism is associated with cognitive impairment, but the mechanism has remained unclear. As subclinical hyperthyroidism is characterized by significantly decreased thyrotropin (TSH) levels, this study aimed to investigate whether TSH regulates cognitive function.Methods: The correlation between TSH and cognitive impairment was investigated in a cross-sectional population study including 382 participants wi...

ea0062p42 | Poster Presentations | EU2019

Severe hypercalcaemia in a young patient

Lin NT , Thomas M

Case History: 16-year-old fit and well lady was referred to endocrinology clinic by GP due to severe hypercalcaemia. She is being investigated for secondary amenorrhea. She is not taking any regular medication. There is a history of hypercalcaemia in the family, her mother has hypercalcaemia and paternal grandfather had hypercalcaemia. She had no signs and symptoms of hypercalcaemia.Investigations: Corrected Calcium: 3.28 mmol/l, Phosphate: 0.60 mmol/l, ...

ea0015p11 | Bone | SFEBES2008

A retrospective audit of the use of pamidronate for fibrous dysplasia

Russell Lin , Cooper Mark

Fibrous dysplasia (FD) is a relatively uncommon condition presenting with combinations of focal bone abnormalities, cutaneous hyperpigmentation and endocrinopathy. It is caused by a post-zygotic mutation in a G-protein coupled receptor (GNAS1) leading to constitutive activation of several hormone signaling pathways. Severely affected patients present in childhood with extensive bone lesions+endocrine disorder e.g. premature puberty (McCune–Albright syndrome) but less seve...